J. A. Léon

发表

Dynamics of progression markers in a non‐study population of human immunodeficiency virus‐1 vertically infected infants with different antiretroviral treatments

M. Muñoz-Fernández, M. Muñoz-Fernandez, S. Resino, 2002, Acta paediatrica.

Cardiovascular risk markers are increased in HIV-infected children with lipodystrophy syndrome.

M. Muñoz-Fernández, D. Micheloud, S. Resino, 2011, The Journal of infection.

LOW IMMUNOLOGIC RESPONSE TO HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN NAIVE VERTICALLY HUMAN IMMUNODEFICIENCY VIRUS TYPE 1-INFECTED CHILDREN WITH SEVERE IMMUNODEFICIENCY

M. Muñoz-Fernández, A. Alvaro-Meca, M. D. de José, 2006, The Pediatric infectious disease journal.

Correlation between the Trofile test and virological response to a short-term maraviroc exposure in HIV-infected patients.

E. Ruiz-Mateos, M. Leal, M. Genebat, 2009, The Journal of antimicrobial chemotherapy.

Impact of antiretroviral protocols on dynamics of AIDS progression markers

S. Sánchez-Ramón, M. Muñoz-Fernandez, J. Ruiz-Contreras, 2002, Archives of disease in childhood.

HIV‐infected children with moderate/severe immune‐suppression: changes in the immune system after highly active antiretroviral therapy

S. Resino, M. Ángeles Muñoz-Fernández, D. Gurbindo, 2004, Clinical and experimental immunology.

Recovery of T‐cell subsets after antiretroviral therapy in HIV‐infected children

M. Muñoz-Fernandez, S. Resino, D. Gurbindo, 2003, European journal of clinical investigation.

Immunological recovery and metabolic disorders in severe immunodeficiency HIV type 1-infected children on highly active antiretroviral therapy.

M. Muñoz-Fernández, M. D. de José, D. Micheloud, 2008, AIDS research and human retroviruses.

CD4+ T-Cell Immunodeficiency Is More Dependent on Immune Activation Than Viral Load in HIV-Infected Children on Highly Active Antiretroviral Therapy

M. Muñoz-Fernández, S. Resino, J. A. Léon, 2006, Journal of acquired immune deficiency syndromes.

Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.

Á. Muñoz-Fernández, D. Micheloud, S. Resino, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children

M. Muñoz-Fernandez, M. D. de José, M. Navarro, 2006, BMC infectious diseases.

TITLE : EFFECTS OF HIGHLY ACTIVE ANTIRETROVIRAL THERAPY WITH NELFINAVIR IN VERTICALLY HIV-1 INFECTED CHILDREN : 3 YEARS OF FOLLOW-UP RUNNING TITLE : LONG-TERM RESPONSE TO NELFINAVIR IN CHILDREN

Á. Muñoz-Fernández, M. Navarro, S. Resino, 2006 .

Impact of long-term viral suppression in CD 4 + recovery of HIV-children on Highly Active Antiretroviral Therapy

M. Muñoz-Fernández, S. Resino, J. Bellón, 2016 .

Impact of long-term viral suppression in CD4+ recovery of HIV-children on Highly Active Antiretroviral Therapy

M. Muñoz-Fernández, M. D. de José, S. Resino, 2006, BMC infectious diseases.

CD8+ T-Cell Numbers Predict the Response to Antiviral Therapy in HIV-1-Infected Children

S. Sánchez-Ramón, M. Muñoz-Fernández, S. Resino, 2003, Pediatric Research.

Experience in IVIg Therapy for Selected Women with Recurrent Reproductive Failure and NK Cell Expansion

S. Sánchez-Ramón, M. López-Hoyos, J. Carbone, 2014, American journal of reproductive immunology.

Long-term response to highly active antiretroviral therapy with lopinavir/ritonavir in pre-treated vertically HIV-infected children.

M. Muñoz-Fernández, P. Soler Palacin, C. Fortuny, 2007, The Journal of antimicrobial chemotherapy.

Characterizing the Immune System After Long-Term Undetectable Viral Load in HIV-1-Infected Children

M. Muñoz-Fernández, M. Navarro, S. Resino, 2003, Journal of Clinical Immunology.

Naïve and memory CD4+ T cells and T cell activation markers in HIV‐1 infected children on HAART

M. Muñoz-Fernández, S. Resino, D. Gurbindo, 2001, Clinical and experimental immunology.

The effects on infants of potent antiretroviral therapy during pregnancy: a report from Spain.

S. Sánchez-Ramón, M. Muñoz-Fernandez, C. Fortuny, 2004, Medical science monitor : international medical journal of experimental and clinical research.

[Relationship between T-cells subsets and prognostic markers in HIV-1-infected children].

M. Muñoz-Fernández, S. Resino, D. Gurbindo, 2001, Medicina clinica.

Is it age or HIV that drives the regulatory T-cells expansion that occurs in older HIV-infected persons?

M. Leal, Y. Pacheco, G. Méndez-Lagares, 2010, Clinical immunology.

[Effects of exercise on the cognition of older women treated with lovastatin].

F. Rodríguez-Rodríguez, Edgardo Molina-Sotomayor, F. Pradas, 2018, Biomedica : revista del Instituto Nacional de Salud.

Detectable Viral Load Aggravates Immunosenescence Features of CD8 T-Cell Subsets in Vertically HIV-Infected Children

E. Ruiz-Mateos, M. Leal, M. M. Pozo-Balado, 2012, Journal of acquired immune deficiency syndromes.

Interleukin-7 levels before highly active antiretroviral therapy may predict CD4+ T-cell recovery and virological failure in HIV-infected children.

M. Muñoz-Fernández, S. Resino, M. Gurbindo, 2006, The Journal of antimicrobial chemotherapy.

[Responses to antiretroviral treatments in vertically HIV-1-infected children].

M. Muñoz-Fernández, S. Resino, J. Ramos, 2002, Medicina clínica (Ed. impresa).

High prevalence of Pneumocystis jiroveci colonization among young HIV-infected patients.

J. A. Léon, V. Friaza, I. Martín-Garrido, 2011, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

New Decision‐Tree Model for Defining the Risk of Reproductive Failure

S. Sánchez-Ramón, Á. Vicente, J. Carbone, 2013, American journal of reproductive immunology.

New Decision‐Tree Model for Defining the Risk of Reproductive Failure

Á. Vicente, J. Carbone, E. Fernandez-cruz, 2013, American journal of reproductive immunology.

Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children

M. D. de José, M. Navarro, S. Resino, 2006, BMC infectious diseases.